Delta-Fly Pharma, Inc.
5 clinical trials · Sponsor
◉ Watch Delta-Fly Pharma, Inc.
| Record | Firm | Date |
|---|---|---|
| DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia (NCT06382168) | Delta-Fly Pharma, Inc. | 2024-06-12 |
| Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage (NCT03926624) | Delta-Fly Pharma, Inc. | 2019-11-22 |
| Trial of DFP-14927 in Advanced Solid Tumors (NCT03943004) | Delta-Fly Pharma, Inc. | 2019-09-30 |
Track Delta-Fly Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.